Sidley represented ProLung, Inc. (LUNG) in its successful proxy contest defense against a dissident group led by its recently terminated CEO, Steven C. Eror.
The dissident group failed its attempt to take control of Prolung’s board of directors through a consent solicitation.
ProLung, Inc., a medical technology company, focuses on developing, marketing, and selling precision predictive analytical medical devices specializing in lung cancer in the United States, European Union, Latin America, and China.
Sidley’s team was led by partner and leader of Sidley’s Shareholder Activism practice Kai Haakon E. Liekefett (Picture) and included associates Jessica Wood, Reuben Zaramian, Will Lawley, Riley Kelleher and Sagar Sritharan.
Involved fees earner: Kai Liekefett – Sidley Austin LLP; Jessica Wood – Sidley Austin LLP; Reuben Zaramian – Sidley Austin LLP; Will Lawley – Sidley Austin LLP; Riley Kelleher – Sidley Austin LLP; Sagar Sritharan – Sidley Austin LLP;
Law Firms: Sidley Austin LLP;
Clients: ProLung, Inc.;